Combination of conventional immunohistochemistry and qRT-PCR to detect ALK rearrangement

Overview of attention for article published in Diagnostic Pathology, January 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
One of the highest-scoring outputs from this source (#1 of 1,120)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

So far, Altmetric has seen 26 news stories from 22 outlets.

The FDA has approved the VENTANA ALK (D5F3) CDx assay as a companion diagnostic to identify patients with ALK -positive non–small…

The FDA has approved the VENTANA ALK (D5F3) CDx assay as a companion diagnostic to identify patients with ALK -positive non–small…

-- About 235,000 people in the US will be diagnosed with lung cancer in 2021, with non-small cell lung cancer (NSCLC…

About 235,000 people in the US will be diagnosed with lung cancer in 2021, with non-small cell lung cancer (NSCLC) accounting…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 22 additional news stories.